Actinogen Medical Limited ACN 086 778 476 Suite 901, Level 9, 109 Pitt Street, Sydney NSW 2000 +61 2 8964 7401 | actinogen.com.au 1 ASX ANNOUNCEMENT Actinogen September 2026 quarterly activity report and Appendix 4C Sydney, 19 October 2026. Actinogen Medical ASX: ACW (“ACW” or “the...
ACW September 2026 quarterly activity report & Appendix 4C
Filed with ASX · · 9 pages · English
Release
Actinogen Medical Limited on 6ix
Story so far
Earlier from Actinogen Medical
- Actinogen XanaMIA pivotal Alzheimer’s disease trial completes final patient visit, with topline results on track for November
- Underwriting of unlisted options completed
- ACW Alzheimers pivotal trial completes last patient visit
- ACW unlisted options fully underwritten
- ACW FY2026 results and outlook
Later from Actinogen Medical
All Actinogen Medical news releasesFollow Actinogen Medical into a list and get an email when it puts out news.
Follow Actinogen Medical